“Two-phase”的搜索结果，显示 121-130 项，共有 4407 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between ... This study consists of two parts to explore BGB-16673 recommended dosing: a part 1 ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

4. 血液科- 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

7. 放射科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning ... ADPKD is a leading cause of end-stage renal disease. ... ADPKD is a leading cause of end-stage renal disease.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. ... (2) Cohort 2 focuses on primary or ...

9. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... Phase 2 part to further assess the effectiveness and safety of JCAR017 monotherapy treatment at the recommended dose. A separate Phase 1 cohort will assess ...